Showing results (1-10 of 315) with videos related to
Sort By:
Pageof 32
Clinical Advances in Hematology & Oncology : H&O|March 25, 2006
Some ethical issues in phase II trials in acute leukemiaPeter F Thall, Elihu H EsteyJournal of Biopharmaceutical Statistics|October 14, 2006
Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerationsPeter F Thall, John D Cook, Elihu H EsteyBiometrics|March 22, 2008
Patient-specific dose finding based on bivariate outcomes and covariatesPeter F Thall, Hoang Q Nguyen, Elihu H EsteyStatistics in Medicine|October 24, 2007
Accounting for patient heterogeneity in phase II clinical trialsJ Kyle Wathen, Peter F Thall, John D Cook, et al.Blood|July 5, 2003
Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AMLElihu H Estey, Peter F Thall, Xuemei Wang, et al.American Journal of Hematology|October 18, 2018
Acute myeloid leukemia: 2019 update on risk-stratification and managementElihu H EsteyBest Practice & Research. Clinical Haematology|March 18, 2008
Older adults: should the paradigm shift from standard therapy?Elihu H EsteyBest Practice & Research. Clinical Haematology|October 21, 2004
Modulation of angiogenesis in patients with myelodysplastic syndromeElihu H EsteyAmerican Journal of Hematology|August 25, 2020
Acute myeloid leukemia: 2021 update on risk-stratification and managementElihu H EsteyPageof 32